Study reports a new method of analyzing the codes found in RNA that can delineate human microbial communities and reveal how they operate.

Researchers have identified a new species of bobtail squid inhabiting Okinawa's waters - dubbed Euprymna brenneri.

Researchers have developed a new method to analyse data from individual human cells, which they say could be a step-change for diagnosing some of the most devastating diseases, including cancer and autoimmune disease.

Researchers have revealed the mechanism that helps pancreatic cancer cells avoid starvation within dense tumors – they hijack a process that pulls nutrients in from their surroundings.

Convolutional neural networks could be used to help identify disease-related genes and genetic pathways that could be targets for drugs.

Researchers have developed a means of storing extensive information in almost any object. The way of storing this information is the same as for living things: in DNA molecules.

In the post-genomic era, the direct cost associated with performing sequencing reactions has diminished, whereas the data processing, storage, management, and interpretation costs have increased exponentially. In this article, we explore how new tools are simplifying the process of genomic data analysis.

In this article, we revisit the many twists and turns of the aducanumab clinical trials and explore the scientific community's response to the latest analysis of the data.

From detecting cancer to microbial infections, and now even fungal infections, PCR has become the gold standard of analyzing gene expression. In this article, we explore how PCR is used as a novel diagnostic strategy to identify clinically important yeast species, as well as to detect mutations that could guide therapeutic decisions for lung cancer patients.

What do we mean by lab of the future? What innovations are required to get there? These are the key themes explored by this year's Lab of the Future Congress, summarized in this article.

In this feature of Technology Networks Explores the CRISPR Revolution, we interview Professor Glenn Cohen, director of Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics.

The measurement of low-molecular-weight metabolites and their intermediates reflects the dynamic response of the body to physiological, pathophysiological and developmental stimulus (e.g., aging). In this article, we explore how metabolomic profiling is advancing an array of scientific disciplines, including medicine and agriculture.